Skip to content

Chromosome 3 Trisomy 3p25 C2931341

Published: July 22, 2026Updated: August 25, 2026

A specific chromosomal duplication involving the 3p25 region of chromosome 3, potentially causing developmental and medical concerns. Treatment focuses on managing individual symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Growth restriction

(growth and endocrine)

Microcephaly

(neurological)

Skeletal abnormalities

(musculoskeletal)

Seizure disorder

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiac Surveillance Program

Regular echocardiograms and cardiology evaluations to monitor for congenital heart defects common in 3p25 trisomy, including septal defects and pulmonary stenosis.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Infant Motor Development Therapy

Specialized therapy program addressing significant hypotonia and motor delays characteristic of 3p25 trisomy through positioning, strengthening, and milestone facilitation.

physical_therapy

Additional treatment options

Seizure Management

Antiepileptic drug therapy when seizure activity is present, with regular EEG monitoring and medication level assessments to optimize control.

medication

Nutritional Support and Feeding Therapy

Comprehensive feeding evaluation and therapy addressing swallowing difficulties, oral motor dysfunction, and failure to thrive often seen in this population.

dietary

Craniofacial Anomaly Correction

Surgical repair of cleft palate, facial asymmetry, or other structural abnormalities identified in 3p25 trisomy, typically staged across development.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 3 Trisomy 3p25 C2931341?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Chromosome 3 Trisomy 3p25 C2931341. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy